Date of Award
2001
Degree Name
Psychology
College
College of Liberal Arts
Type of Degree
M.A.
Document Type
Thesis
First Advisor
Marianna Footo-Linz
Second Advisor
Stephen P. Mewalett
Abstract
This was an open-label study of levetiracetam in children with autism. Many anticonvulsant medications are used for management of externalizing behaviors and mood stability in autism; however, they are not consistently effective and adverse reactions limit their use. The objective of this study was to test the following research questions: (1) to determine whether levetiracetam reduces problematic externalizing behaviors in children with autism, and (2) to determine whether a nootropic effect from levetiracetam may be seen in cognition, memory, and/or language function in children with autism. Evaluations were gathered pre-treatment and during treatment using a battery of cognitive and behavioral measures. During-treatment evaluations were performed after an average of 4.1 weeks taking levetiracetam. Data were analyzed using one-tailed, Student's correlated samples t-tests. Levetiracetam improves hyperactivity, impulsivity and mood stability features of autism. Sensory response measures were significantly worse with treatment. A nootropic effect was not found. Further study is indicated using a double blind, placebo-controlled research design.
Subject(s)
Autism in children.
Autism -- Treatment -- Research.
Nootropic agents.
Recommended Citation
Samsock, Teresa C., "An Open Label Study of the Effects of Levetiracetam in Children with Autism" (2001). Theses, Dissertations and Capstones. 2076.
https://mds.marshall.edu/etd/2076
Included in
Chemicals and Drugs Commons, Clinical Psychology Commons, Experimental Analysis of Behavior Commons
